中外製薬: Company report

Sun	Mon	Tue	Wed	Thu	Fri	Sat
	1 -	2 -	3 -	4 -	5 -	6 -
7 -	8 -	9 -	10 -	11 -	12 -	13 -
14 -	15 -	16 -	17 -	18 -	19 -	20 -
21 -	22 -	23 -	24 -	25 -	26 -	27 -
28 -	29 -	30 -

Total Rating	Comment	Note
54	Good.	2012-12-31 Consolidated

Total Rating

Comment

Note

Good.

2012-12-31 Consolidated

Efficiency Rating	Profit Rating	Growth Rating	Scale Rating	Stability Rating
17	87	39	87	43

Efficiency Rating

Profit Rating

Growth Rating

Scale Rating

Stability Rating

中外製薬: Credit Rating (Bankruptcy Risk)

Rating	Comment	Note
AA	Credit is very high, slightly affected by biz environs.	2012-12-31 Consolidated

Rating

Comment

Note

Credit is very high, slightly affected by biz environs.

2012-12-31 Consolidated

*Detailed analysis is the following page of EDIUNET.

Company	EDINET Code	Ticker symbol	Market	Month	Industry
中外製薬	E00932	1303	TSE 1st	12	Chemicals

Company

EDINET Code

Ticker symbol

Market

Month

Industry

中外製薬

E00932

1303

TSE 1st

Chemicals

くすりの会社の「そうぞうLABO」｜中外製薬 - chugai-pharm.co.jp

くすりの会社の「そうぞうLABO」｜中外製薬 chugai-pharm.co.jp [2024/04/25]

中外製薬、一時6%安想定下回る決算に失望銘柄診断 - Nikkei Asia

中外製薬、一時6%安想定下回る決算に失望銘柄診断 Nikkei Asia [2024/04/25]

前日に動いた銘柄 part2 櫻護謨、スマートバリュー、中外製薬、など(フィスコ) - Yahoo!ファイナンス - finance.yahoo.co.jp

前日に動いた銘柄 part2 櫻護謨、スマートバリュー、中外製薬、など(フィスコ) - Yahoo!ファイナンス finance.yahoo.co.jp [2024/04/26]

【1～3月期】中外、売上高24.1％減収「ロナプリーブ」納入完了や後発品浸透で - 日刊薬業

【1～3月期】中外、売上高24.1％減収「ロナプリーブ」納入完了や後発品浸透で日刊薬業 [2024/04/24]

【IR広告】中外製薬持続的な成長と株主還元の両者に迫る - トウシル

【IR広告】中外製薬持続的な成長と株主還元の両者に迫るトウシル [2024/04/16]

Company	Rating
TAISHO PHARMACEU..	72
Otsuka Holdings	71
塩野義製薬	66

Company

Rating

TAISHO PHARMACEU..

Otsuka Holdings

塩野義製薬

中外製薬: Financial Rating

Rating Detail

中外製薬: Credit Rating (Bankruptcy Risk)

Company Information and Reputation powered by Googleニュース

Related Industry Ranking (*TOP 3)

Caution